Strikingly, ATZ prevented the increase in blood pressure and the HFD-induced obesity as observed by lower body weight, WAT index, triglycerides, NEFA, and leptin in plasma. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.